<DOC>
	<DOCNO>NCT00231712</DOCNO>
	<brief_summary>The purpose study conduct analysis influence 1. conventional chemotherapy 2. high-dose chemotherapy follow autologous stem cell transplant 3. high-dose chemotherapy follow allogeneic stem cell transplant recovery immune system . Detailed analysis help well understand pathway recovery immune system follow chemotherapy well pathways recovery immune system follow autologous allogeneic stem cell transplantation .</brief_summary>
	<brief_title>Immuno 1 : Immune Reconstitution Following Conventional High-Dose Chemotherapy With Stem Cell Transplant</brief_title>
	<detailed_description>Detailed analysis perform preselected time point follow therapy - standard flow cytometry combination intracellular cytokine/antigen stain - spectratype analysis - TREC assay</detailed_description>
	<mesh_term>Medulloblastoma</mesh_term>
	<criteria>Acute leukemia treat accord current ALLBFM 2002 protocol Solid tumor treat accord current GPOHprotocol Medulloblastoma treat accord HIT2000 protocol Highdose chemotherapy follow autologous stem cell transplantation Highdose chemotherapy follow allogeneic stem cell transplantation Written consent accord institutional guideline No write consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>prospective analysis immune function ,</keyword>
	<keyword>spectratype</keyword>
	<keyword>immunoscope</keyword>
	<keyword>TREC analysis</keyword>
	<keyword>solid tumor</keyword>
</DOC>